Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$419M |
| 2 |
Truist Financial
TFC
|
+$351M |
| 3 |
Mastercard
MA
|
+$218M |
| 4 |
PPL
PPL Corp
PPL
|
+$193M |
| 5 |
Cognizant
CTSH
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$592M |
| 2 |
IBM
IBM
|
+$320M |
| 3 |
Wells Fargo
WFC
|
+$306M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$290M |
| 5 |
Walt Disney
DIS
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.85% |
| 2 | Financials | 13.92% |
| 3 | Healthcare | 13.77% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Adtran
ADTN
$684M
| $6.52M | ﹤0.01% |
659,457
-168,649
| -20% | -$1.61M |
|
2202
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
| $6.51M | ﹤0.01% |
54,648
-650
| -1% | -$74.9K |
|
2203
Ennis
EBF
$559M
| $6.49M | ﹤0.01% |
299,948
-56,398
| -16% | -$1.15M |
|
2204
Schwab Short-Term US Treasury ETF
SCHO
$13B
| $6.49M | ﹤0.01% |
257,118
+35,578
| +16% | +$899K |
|
|
ITCI
2205
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.48M | ﹤0.01% |
188,881
-1,316
| -0.7% | -$15.8K |
|
|
BRSL
2206
Brightstar Lottery PLC
BRSL
$2.17B
| $6.46M | ﹤0.01% |
431,289
+1,945
| +0.5% | +$27.7K |
|
2207
Yeti Holdings
YETI
$3.38B
| $6.45M | ﹤0.01% |
185,484
+51,878
| +39% | +$1.63M |
|
|
CUTR
2208
DELISTED
Cutera, Inc.
CUTR
| $6.44M | ﹤0.01% |
179,910
+8,709
| +5% | +$294K |
|
|
DRNA
2209
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $6.44M | ﹤0.01% |
292,454
+81,638
| +39% | +$1.64M |
|
|
NVTA
2210
DELISTED
Invitae Corporation
NVTA
| $6.44M | ﹤0.01% |
399,116
-1,214
| -0.3% | -$21.5K |
|
|
CWEN.A
2211
DELISTED
Clearway Energy Class A
CWEN.A
| $6.44M | ﹤0.01% |
336,631
-195,260
| -37% | -$3.6M |
|
2212
1st Source
SRCE
$2.13B
| $6.43M | ﹤0.01% |
123,885
+2,996
| +2% | +$151K |
|
|
TPTX
2213
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $6.4M | ﹤0.01% |
102,682
+55,833
| +119% | +$2.66M |
|
2214
American Vanguard Corp
AVD
$62.5M
| $6.38M | ﹤0.01% |
327,852
-10,949
| -3% | -$172K |
|
2215
Amneal Pharmaceuticals
AMRX
$6.32B
| $6.37M | ﹤0.01% |
1,322,416
+787,166
| +147% | +$2.74M |
|
2216
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $6.35M | ﹤0.01% |
170,379
+3,258
| +2% | +$109K |
|
2217
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $6.31M | ﹤0.01% |
61,974
-1,440
| -2% | -$138K |
|
2218
Columbus McKinnon
CMCO
$556M
| $6.31M | ﹤0.01% |
157,678
-4,058
| -3% | -$157K |
|
|
RVI
2219
DELISTED
Retail Value Inc. Common Shares
RVI
| $6.31M | ﹤0.01% |
1,867,488
+925,840
| +98% | +$3.1M |
|
2220
Cushman & Wakefield Ltd
CWK
$3.38B
| $6.3M | ﹤0.01% |
308,376
+27,057
| +10% | +$509K |
|
2221
Univest Financial
UVSP
$1.19B
| $6.3M | ﹤0.01% |
235,289
+41,717
| +22% | +$1.08M |
|
2222
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
| $6.28M | ﹤0.01% |
49,087
-12,779
| -21% | -$1.63M |
|
|
FIT
2223
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $6.28M | ﹤0.01% |
955,795
+17,955
| +2% | +$105K |
|
|
SRDX
2224
DELISTED
Surmodics
SRDX
| $6.28M | ﹤0.01% |
151,519
+260
| +0.2% | +$10.9K |
|
2225
Movado Group
MOV
$803M
| $6.23M | ﹤0.01% |
286,447
+7,934
| +3% | +$186K |
|
Similar funds
Bank of New York Mellon's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of New York Mellon held 4,341 positions worth $388B, up 6.4% from $364B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bank of New York Mellon's Q4 2019 filing shows 131 new, 1,843 increased, 1,854 reduced and 165 closed positions. Its largest new stake was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M. The largest sale was Celgene Corp, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2019 buy was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M.
- Bank of New York Mellon added most to Bristol-Myers Squibb in Q4 2019, an estimated $419M increase.
- Bank of New York Mellon's biggest Q4 2019 reduction was IBM, cutting an estimated $320M.
- Bank of New York Mellon fully exited Celgene Corp in Q4 2019, selling an estimated $592M.
- Bank of New York Mellon's ten largest holdings make up 16% of its $388B portfolio in Q4 2019.
- Bank of New York Mellon opened 131 new positions and closed 165 in Q4 2019.
- Bank of New York Mellon's portfolio value rose 6.4% quarter-over-quarter to $388B.
Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.